According to Sonoma Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -1,48ย โฌ. In 2018 the company made an earnings per share (EPS) of -351,56ย โฌ an increase over its 2017 EPS that were of -449,02ย โฌ.